To explore the value of the enhanced recovery after surgery (ERAS) concept that based on multimodal analgesia in laparoscopic radical prostatectomy.

Perioperative clinical data of patients underwent laparoscopic radical prostatectomy in our hospital from January 2017 to December 2017 were analyzed retrospectively. According to whether the patients received ERAS treatment, they were divided into ERAS group and control group. There were 11 patients in ERAS group received ERAS perioperative treatment. There were 24 patients in control group received traditional perioperative treatment.

There was no difference in age, ASA classification and cardiac function classification between the two groups. Compared with the control group, the ERAS group was significantly reduced in intraoperative infusion volume [(7.2±2.2) ml vs (10.7±3.8) ml/kg/h,P=0.009]. The postoperative hospitalization time was significantly shortened [(7.5±2.8) d vs (10.3±2.8) d,P=0.008]. The first time of anal exhaust after operation was shortened [(1.4±0.9) d vs (2.4±0.9) d,P=0.018]. Compared with the control group, the total cost of hospitalization and the anesthesia cost were both increased in ERAS group [(75 129±21 217) vs (55 201±19 109) yuan,P=0.009; (5 538±4 431) vs (3 122±726) yuan,P=0.01]. Besides, there was no difference in the length of total hospitalization time, the proportion of the anesthesia cost in total cost between the two groups.

The application of ERAS concept that based on multimodal analgesia in laparoscopic radical prostatectomy enable to accelerate the recovery of gastrointestinal function of patients, shorten the postoperative hospitalization time, as well as, not to increase the occurrence of perioperative complications.